Kevin C. Tang, Chief Executive Officer, 10% Owner, Officer, Chief Financial Officer at Odonate Therapeutics, Inc. (ODT), bought 46,737 shares at $26.93 ($1.3M) on 2018-02-27, disclosed to the SEC on 2018-02-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.99 | 2,175 | $61K | 4.8% |
| 2 | $27.99 | 2,175 | $61K | 4.8% |
| 3 | $27.32 | 3,359 | $92K | 7.2% |
| 4 | $27.32 | 3,359 | $92K | 7.2% |
| 5 | $27.70 | 10,000 | $277K | 21.7% |
| 6 | $28.00 | 487 |
| $14K |
| 1.1% |
| 7 | $26.93 | 5,950 | $160K | 12.5% |
| 8 | $26.93 | 5,950 | $160K | 12.5% |
| 9 | $27.26 | 6,641 | $181K | 14.2% |
| 10 | $27.26 | 6,641 | $181K | 14.2% |
| Total | $27.35 avg | 46,737 | $1.3M | 100% |
| Filing → |
| ODT | BUY | 2020-12-23 | $8.4M | — | Filing → |
| LJPC | BUY | 2020-08-14 | $3.2M | — | Filing → |
| LJPC | BUY | 2020-02-03 | $1.7M | — | Filing → |